Medicare Enrolled
Dr. Brian Berry, M.D., PHD
Medical Oncology · Bradenton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berry? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berry
Dr. Brian Berry is a medical oncology in Bradenton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Berry performed 249,291 Medicare services across 5,619 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berry received a total of $11,391 from 85 pharmaceutical and/or device companies across 606 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 8% volume in FL$ $11,391 industry payments
Medicare Practice Summary
Medicare Utilization ↗249,291
Medicare services
Top 8% in FL for medical oncology
5,619
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,465 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 51,510 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 31,500 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 28,260 | $18 | $51 |
| Pembrolizumab injection (Keytruda) | 22,400 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 19,760 | $1 | $5 |
| Daratumumab injection (Darzalex) | 18,540 | $38 | $110 |
| Paclitaxel chemotherapy injection | 16,048 | $0 | $2 |
| Iron infusion (Injectafer) | 12,000 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 7,680 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 5,820 | $36 | $108 |
| Injection, eflapegrastim-xnst, 0.1 mg | 5,016 | $26 | $116 |
| Dexamethasone injection (steroid) | 4,144 | $0 | $3 |
| Blood draw (venipuncture) | 3,386 | $8 | $9 |
| Complete blood count (CBC) with differential | 3,161 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,770 | $1 | $28 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,473 | $24 | $185 |
| Office visit, established patient (30-39 min) | 1,914 | $95 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 1,332 | $0 | $9 |
| Drug injection, under skin or into muscle | 1,322 | $10 | $69 |
| Injection, fulvestrant, 25 mg | 960 | $8 | $132 |
| Injection of additional new drug or substance into vein | 810 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 768 | $96 | $378 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 613 | $3 | $205 |
| Office visit, established patient (20-29 min) | 580 | $63 | $239 |
| Injection, leucovorin calcium, per 50 mg | 578 | $3 | $12 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 495 | $47 | $189 |
| Injection, fluorouracil, 500 mg | 478 | $2 | $7 |
| Injection, carboplatin, 50 mg | 466 | $2 | $41 |
| Red blood count automated, with additional calculations | 454 | $5 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 419 | $21 | $84 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 385 | $1 | $6 |
| Administration of chemotherapy into vein, each additional hour | 295 | $22 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 295 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 239 | $15 | $56 |
| Infusion into a vein for hydration, each additional hour | 230 | $9 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 227 | $48 | $178 |
| Office visit, established patient, complex (40-54 min) | 223 | $135 | $474 |
| Injection, zoledronic acid, 1 mg | 213 | $6 | $69 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 165 | $54 | $206 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 148 | $3 | $11 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 141 | $25 | $89 |
| New patient office visit, complex (60-74 min) | 139 | $156 | $585 |
| Infusion, normal saline solution , 1000 cc | 115 | $2 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 109 | $136 | $562 |
| Injection of drug or substance into vein | 92 | $27 | $156 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 82 | $1 | $4 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 76 | $16 | $59 |
| Infusion into a vein for hydration, 31-60 minutes | 75 | $25 | $156 |
| Administration of additional new drug or substance into vein using push technique | 70 | $42 | $170 |
| Automated urinalysis | 64 | $2 | $8 |
| Drawing of blood for a medical problem | 62 | $54 | $277 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 57 | $1 | $7 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 43 | $124 | $637 |
| New patient office visit (45-59 min) | 33 | $116 | $453 |
| New patient office visit (30-44 min) | 20 | $73 | $298 |
| Hospital follow-up visit, moderate complexity | 13 | $63 | $197 |
| Office visit, established patient (10-19 min) | 12 | $32 | $147 |
| Transitional care management services for problem of high complexity | 11 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.5% high complexity
67.3% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,391
Total received (2018-2024)
Avg $1,627/year across 7 years
Top 41% in FL for medical oncology
85
Companies
606
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,077 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,601
2023$2,230
2022$1,302
2021$1,656
2020$1,240
2019$1,406
2018$956
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,016
Novartis Pharmaceuticals Corporation
$677
Janssen Biotech, Inc.
$622
Celgene Corporation
$583
PFIZER INC.
$496
Amgen Inc.
$443
GENZYME CORPORATION
$434
Merck Sharp & Dohme LLC
$431
Merck Sharp & Dohme Corporation
$382
Astellas Pharma US Inc
$364
Lilly USA, LLC
$335
AstraZeneca Pharmaceuticals LP
$331
Gilead Sciences, Inc.
$316
Incyte Corporation
$300
Genentech USA, Inc.
$296
Daiichi Sankyo Inc.
$270
GlaxoSmithKline, LLC.
$270
Seagen Inc.
$258
BeiGene USA, Inc.
$214
Takeda Pharmaceuticals U.S.A., Inc.
$185
Kite Pharma, Inc.
$171
ABBVIE INC.
$168
Exelixis Inc.
$147
Regeneron Healthcare Solutions, Inc.
$144
ARRAY BIOPHARMA INC
$138
AbbVie Inc.
$123
Eisai Inc.
$117
Pharmacyclics LLC, An AbbVie Company
$111
SANOFI-AVENTIS U.S. LLC
$100
JAZZ PHARMACEUTICALS INC.
$100
Epizyme, Inc.,
$84
Stemline Therapeutics Inc.
$77
Rigel Pharmaceuticals, Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$73
Deciphera Pharmaceuticals Inc.
$71
AbbVie, Inc.
$71
INSYS Therapeutics Inc
$67
TerSera Therapeutics LLC
$59
Karyopharm Therapeutics Inc.
$58
Bayer HealthCare Pharmaceuticals Inc.
$57
Heron Therapeutics, Inc.
$56
PUMA BIOTECHNOLOGY, INC.
$55
Dendreon Pharmaceuticals LLC
$50
Taiho Oncology, Inc.
$50
Jazz Pharmaceuticals Inc.
$46
Dova Pharmaceuticals
$39
Servier Pharmaceuticals LLC
$37
SpringWorks Therapeutics, Inc.
$36
TAIHO ONCOLOGY, INC.
$36
ADC Therapeutics America, Inc.
$36
Mirati Therapeutics, Inc.
$34
PharmaEssentia USA Corporation
$34
Pharmacosmos Therapeutics Inc.
$34
Sobi, Inc
$32
SERVIER PHARMACEUTICALS LLC
$32
Puma Biotechnology, Inc.
$29
Myriad Genetic Laboratories, Inc.
$29
Myovant Sciences Inc.
$27
EMD Serono, Inc.
$27
Aurobindo Pharma USA, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
Teva Pharmaceuticals USA, Inc.
$23
Array BioPharma Inc.
$21
Secura Bio, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$20
Alnylam Pharmaceuticals Inc.
$18
Blueprint Medicines Corporation
$18
TG Therapeutics, Inc.
$18
AVEO Pharmaceuticals, Inc.
$17
Aveo Pharmaceuticals, Inc.
$17
Epizyme, Inc.
$17
Genmab U.S., Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Iovance Biotherapeutics, Inc.
$17
Janssen Pharmaceuticals, Inc
$16
Helsinn Therapeutics (U.S.), Inc.
$16
Sumitomo Pharma America, Inc.
$15
Acrotech Biopharma Inc.
$14
Agios Pharmaceuticals, Inc.
$13
Acceleron Pharma, Inc.
$13
NanoString Technologies, Inc.
$12
Acrotech Biopharma LLC
$12
Spectrum Pharmaceuticals Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Sunovion Pharmaceuticals Inc.
$11
Top 3 companies account for 20.3% of total payments
Associated products mentioned in payments ›
AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BROVANA · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · HEMADY · IBRANCE · IMBRUVICA · INLYTA · INQOVI · INREBIC · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONCASPAR · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Sustol · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
18
Per 100K population
4.3
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Berry is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Berry experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Berry performed 51,510 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berry receive payments from pharmaceutical companies?
Yes. Dr. Berry received a total of $11,391 from 85 companies across 606 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berry's costs compare to other medical oncologys in Bradenton?
Dr. Berry's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Bradenton
Browse medical oncologys in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology